Recurrent Marginal Zone Lymphoma with Bone Marrow Involvement Detected by ¹⁸F-FDG PET/CT and Biopsy: A Diagnostic Challenge

Yeong-Shin Hsiao; Shu-Chane Shen; Shih-Chuan Hsiao

doi:10.12659/AJCR.943275

22 April 2024 : Case report Taiwan

Recurrent Marginal Zone Lymphoma with Bone Marrow Involvement Detected by ¹⁸F-FDG PET/CT and Biopsy: A Diagnostic Challenge

Mistake in diagnosis

Yeong-Shin Hsiao^1EF, Shu-Chane Shen^2BCD, Shih-Chuan Hsiao^3BCDEF*

DOI: 10.12659/AJCR.943275

Am J Case Rep 2024; 25:e943275

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 4. Imaging after treatment, on June 7, 2022. (A) Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) scan shows subtle 18F-FDG uptake (maximum standardized uptake value (SUVmax) 2.69 in the spine and 1.02 in the pelvis). (B) Maximum-intensity projection (MIP) image shows no obvious bone marrow uptake (BMU) compared to Figure 1.

Back to the Article

Recurrent Marginal Zone Lymphoma with Bone Marrow Involvement Detected by ¹⁸F-FDG PET/CT and Biopsy: A Diagnostic Challenge

Your Privacy